OBI — Ondine Biomedical Share News
0.000.00%
- £41.58m
- £40.21m
- CA$1.20m
REG - Ondine Biomedical - Notice of Results and Investor Presentation
AnnouncementREG - Ondine Biomedical - Notice of AGM
AnnouncementREG - Ondine Biomedical - Issue of Equity
AnnouncementRCS - Ondine Biomedical - Ondine reports successful food pathogen study
AnnouncementRCS - Ondine Biomedical - Ondine Phase 2 results presented at ECCMID 2023
AnnouncementREG - Ondine Biomedical - Progress Update
AnnouncementRCS - Ondine Biomedical - Ondine food-safe photodisinfection update
AnnouncementRCS - Ondine Biomedical - Lux Vitae advocates Steriwave for COVID prevention
AnnouncementREG - Ondine Biomedical - Ottawa hospital presents Steriwave study results
AnnouncementREG - Ondine Biomedical - Grant of Share Options
AnnouncementREG - Ondine Biomedical - Ondine’s APDT reduces SARS-CoV-2 infectivity
AnnouncementREG - Ondine Biomedical - TR-1: Notification of major holdings
AnnouncementRCS - Ondine Biomedical - New photodisinfection study published
AnnouncementREG - Ondine Biomedical - Price Monitoring Extension
AnnouncementREG - Ondine Biomedical - Second Price Monitoring Extn
AnnouncementREG - Ondine Biomedical - Appointment of Nominated Adviser
AnnouncementREG - Ondine Biomedical - Steriwave receives regulatory approval in Mexico
AnnouncementRCS - Ondine Biomedical - Ondine receives funding for meat photodisinfection
AnnouncementRCS - Ondine Biomedical - Ondine receives funding for meat photodisinfection
Announcement